This content is only available within our institutional offering.
22 Oct 2019
LIBERUM: Morning Comment
Novartis AG (NOVN:SWX), 0 | Just Eat Plc (JE.:LON), 0 | Reckitt Benckiser Group plc (RKT:LON), 4,521 | Whitbread PLC (WTB:LON), 3,334 | Travis Perkins plc (TPK:LON), 728 | ams-OSRAM AG (AMS:SWX), 0 | On The Beach Group PLC (OTB:LON), 165 | Pinewood Technologies Group PLC (PINE:LON), 38.4 | Sylvania Platinum Ltd. (SLP:LON), 58.0 | Quilter Plc (QLT:LON), 107 | Hargreaves Lansdown plc (HL:LON), 739 | IntegraFin Holdings PLC (IHP:LON), 279 | AJ Bell Plc (AJB:LON), 304 | Oxford BioMedica plc (OXB:LON), 201
Sign in
This content is only available to commercial clients. Sign in if you have access or contact support@research-tree.com to set up a commercial account
This content is only available to commercial clients. Sign in if you have access or contact support@research-tree.com to set up a commercial account
LIBERUM: Morning Comment
Novartis AG (NOVN:SWX), 0 | Just Eat Plc (JE.:LON), 0 | Reckitt Benckiser Group plc (RKT:LON), 4,521 | Whitbread PLC (WTB:LON), 3,334 | Travis Perkins plc (TPK:LON), 728 | ams-OSRAM AG (AMS:SWX), 0 | On The Beach Group PLC (OTB:LON), 165 | Pinewood Technologies Group PLC (PINE:LON), 38.4 | Sylvania Platinum Ltd. (SLP:LON), 58.0 | Quilter Plc (QLT:LON), 107 | Hargreaves Lansdown plc (HL:LON), 739 | IntegraFin Holdings PLC (IHP:LON), 279 | AJ Bell Plc (AJB:LON), 304 | Oxford BioMedica plc (OXB:LON), 201
- Published:
22 Oct 2019 -
Author:
Liberum Research Team -
Pages:
6